Patents by Inventor Robert Drillien

Robert Drillien has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Viral strains derived from the vaccinia virus Lister VACV-107 and uses thereof
    Patent number: 8623381
    Abstract: The present invention relates to viral strains derived from the vaccinia virus Lister VACV-107 and to pharmaceutical composition containing the viral strains. More particularly, the present invention relates to a viral strain derived from the vaccinia virus Lister VACV-107 wherein strain contains in its genomic sequence (SEQ ID N°1) at least one deletion selected from the group consisting of: deletion of the nucleotides 19758 to 28309 in the sequence ID NO°1 (?18), deletion of the nucleotides 161293 to 164811 in the sequence ID NO°1 (?20), deletion of the nucleotides 181231 to 183304 in the sequence ID NO°1 (?21), deletion of the nucleotides 6118 to 9677 in the sequence ID NO°1 (?22), deletion of the nucleotides 1833 to 3574 and 185848 to 187589 in the sequence ID NO°1 (?23).
    Type: Grant
    Filed: September 18, 2009
    Date of Patent: January 7, 2014
    Assignee: Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Jean-marc Crance, Daniel Garin, Daniele Gratier, Anne-Laure Favier, Robert Drillien, Matthias Hebben, Daniele Spehner, Karine Pradeau
  • VIRAL STRAINS DERIVED FROM THE VACCINIA VIRUS LISTER VACV-107 AND USES THEREOF
    Publication number: 20110171256
    Abstract: The present invention relates to viral strains derived from the vaccinia virus Lister VACV-107 and to pharmaceutical composition containing the viral strains. More particularly, the present invention relates to a viral strain derived from the vaccinia virus Lister VACV-107 wherein strain contains in its genomic sequence (SEQ ID N°1) at least one deletion selected from the group consisting of: deletion of the nucleotides 19758 to 28309 in the sequence ID NO°1 (?18), deletion of the nucleotides 161293 to 164811 in the sequence ID NO°1 (?20), deletion of the nucleotides 181231 to 183304 in the sequence ID NO°1 (?21), deletion of the nucleotides 6118 to 9677 in the sequence ID NO°1 (?22), deletion of the nucleotides 1833 to 3574 and 185848 to 187589 in the sequence ID NO°1 (?23).
    Type: Application
    Filed: September 18, 2009
    Publication date: July 14, 2011
    Inventors: Jean-marc Crance, Daniel Garin, Daniele Gratier, Anne-Laure Favier, Robert Drillien, Matthias Hebben, Daniele Spehner, Karine Pradeau
  • Vaccine against rabies and process for preparation thereof
    Patent number: 6024953
    Abstract: The present invention relates to a vaccinia virus, characterised in that it contains all or part of a DNA sequence (I) coding for an antigenic glycoprotein of rabies.
    Type: Grant
    Filed: April 21, 1994
    Date of Patent: February 15, 2000
    Assignee: Transgene S.A.
    Inventors: Richard Lathe, Marie-Paule Kieny, Robert Drillien, Jean-Pierre Lecocq
  • Vaccine against rabies and process for preparation thereof
    Patent number: 5830477
    Abstract: The present invention relates to a vaccinia virus, characterized in that it contains all or part of a DNA sequence (I) coding for an antigenic glycoprotein of rabies.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: November 3, 1998
    Assignee: Transgene S.A.
    Inventors: Richard Lathe, Marie-Paule Kieny, Robert Drillien, Jean-Pierre Lecocq
  • DNA sequences, vectors, recombinant viruses and method which employs recombinant vaccinia viruses capable of muliplying in CHO cells
    Patent number: 5830688
    Abstract: The DNA sequence of this invention, isolated from cowpox virus, participates in the multiplication of this virus in CHO cells. This DNA may be incorporated into vectors and recombinant viruses (e.g., recombinant vaccinia viruses). Such recombinant viruses are capable of multiplying in CHO cells.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: November 3, 1998
    Assignee: Transgene, S.A.
    Inventors: Robert Drillien, Daniele Spehner
  • Recombinant fowlpox virus
    Patent number: 5180675
    Abstract: Recombinant fowlpox virus, derived from an attenuated strain, which has integrated in a non-coding intergenic region of its genome a DNA sequence coding for a heterologous protein.
    Type: Grant
    Filed: October 28, 1988
    Date of Patent: January 19, 1993
    Assignee: Transgene, S. A.
    Inventors: Robert Drillien, Daniele Spehner